Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 12, 1988 - Issue 5-6
4
Views
0
CrossRef citations to date
0
Altmetric
Original Article

The Use of Restriction Fragment Length Polymorphisms for Prenatal Diagnosis: The Estimation of Diagnosable Rate of Multiple Genetic Markers and its use in Detecting β-Thalassemia in a Chinese Population

&
Pages 773-786 | Received 22 Dec 1987, Accepted 01 Jun 1988, Published online: 07 Jul 2009
 

Abstract

As a codominant genetic marker, restriction fragment length polymorphism (RFLP) has been widely applied to the prenatal diagnosis of some genetic diseases. To evaluate the usefulness of the genetic markers in prenatal diagnosis, a parameter, the diagnosable rate or the proportion of diagnosable matings, is estimated when two or more genetic markers are used. The assessment is based on the distribution of haplotypes.

By using the data of the distribution of haplotypes of β-A (normal) and β-T (β-thalassemia) chromosomes in a Chinese population and the formula given, it is easy to calculate the different diagnosable rates of all the combinations of seven given genetic markers. The results could help us to find an appropriate combination of genetic markers in prenatal diagnosis and, therefore, makes it possible to obtain a sufficiently high diagnosable value with a limited number of genetic markers.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.